FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnoloy and deals with compositions for production of vaccine against Neisseria meningitidis, which represent conjugates of different serogroups of N. meningitides with protein-carrier, selected from bacterial toxins or anatoxins, with specified size, in determination by gel-penetrating chromatography (GPC) and/or definite molecular weight in determination by exclusion chromatography with detecting by photometry of multi-angle light diffusion (SEC-MALS).
EFFECT: conjugates of claimed sizes, representing saccharide fragments, are applied in combination into polyvalent vaccine.
6 cl, 11 dwg
Authors
Dates
2011-06-27—Published
2005-06-21—Filed